1.3550
-0.0150
(-1.09%)
As of 1:03:13 PM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-131,712.0000
-132,263.0000
-248,208.0000
-162,870.0000
-39,229.0000
Investing Cash Flow
34,755.0000
112,665.0000
166,751.0000
-324,023.0000
-161,076.0000
Financing Cash Flow
96,582.0000
85.0000
9,207.0000
453,129.0000
282,838.0000
End Cash Position
48,136.0000
57,047.0000
76,560.0000
148,810.0000
182,574.0000
Capital Expenditure
-813.0000
-6,153.0000
-35,566.0000
-50,704.0000
-4,932.0000
Issuance of Capital Stock
--
--
--
411,735.0000
272,693.0000
Free Cash Flow
-132,525.0000
-138,416.0000
-283,774.0000
-213,574.0000
-44,161.0000
12/31/2020 - 10/1/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ALLO Allogene Therapeutics, Inc.
1.8850
-1.82%
CRBU Caribou Biosciences, Inc.
1.5252
+16.43%
NKTX Nkarta, Inc.
2.4250
+2.75%
BEAM Beam Therapeutics Inc.
27.20
-0.29%
ZNTL Zentalis Pharmaceuticals, Inc.
1.7450
+5.12%
IPSC Century Therapeutics, Inc.
0.8525
+0.29%
VERV Verve Therapeutics, Inc.
7.83
+5.60%
ATRA Atara Biotherapeutics, Inc.
8.59
+1.18%
ALXO ALX Oncology Holdings Inc.
1.4050
+7.66%
NTLA Intellia Therapeutics, Inc.
10.57
+0.57%